Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Circulation|March 29, 2001
Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivoR K Kharbanda, M Peters, B Walton, et al.Journal of Virology|September 29, 2004
Identification of proteins associated with murine cytomegalovirus virionsLisa M Kattenhorn, Ryan Mills, Markus Wagner, et al.Human Gene Therapy|November 30, 2016
Adeno-Associated Virus Gene Therapy for Liver DiseaseLisa M Kattenhorn, Christopher H Tipper, Lorelei Stoica, et al.Circulation|September 25, 2001
Vascular dysfunction after repair of coarctation of the aorta: impact of early surgeryM de Divitiis, C Pilla, M Kattenhorn, et al.Molecular Therapy. Methods & Clinical Development|December 10, 2016
Impact of intravenous infusion time on AAV8 vector pharmacokinetics, safety, and liver transduction in cynomolgus macaquesJenny A Greig, Jayme Ml Nordin, Erin Bote, et al.Toxicologic Pathology|October 18, 2021
Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus VectorsJulie A Hutt, Basel T Assaf, Brad Bolon, et al.Human Gene Therapy|October 15, 2021
Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia AJenny A Greig, Melanie K Smith, Jayme M L Nordin, et al.Circulation Research|June 18, 2002
Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial functionC P M Leeson, A D Hingorani, M J Mullen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 2, 2019
Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing AntibodiesMatthew R Gardner, Ina Fetzer, Lisa M Kattenhorn, et al.Science Translational Medicine|July 26, 2019
AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challengesMatthew R Gardner, Christoph H Fellinger, Lisa M Kattenhorn, et al.Pageof 3